BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Ta...(rik has eight additional drugdiscovery r...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
Date:3/17/2008
rik has eight additional drug discovery research programs, and has generated a patent portfolio of more than 450 patents and pending patent applications worldwide.
About ASKA:
ASKA, located in Tokyo, Japan, is a research and development (R&D)
oriented company, which contributes to the society by developing and
providing innovative pharmaceutical products with concentrating its
management resources to the specific therapeutic areas. Additional
information about ASKA is available through its corporate website,
http://www.aska-pharma.co.jp/english/index.html. ASKA and BioNumerik have formed
KI Pharmaceuticals, Inc., located in Tokyo, Japan, as a joint venture aimed
at developing a broad portfolio of new compounds to distribute and market
in Japan.
Contact:
BioNumerik Pharmaceuticals, Inc.
Public Relations Department
(210) 614-1701, ext. 500
email: publicrelations@bnpi.com
'/>"/>
| SOURCE BioNumerik Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
2. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
3. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
4. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
7. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
8. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
9. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
10. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
11. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
Post Your Comments:
(Date:11/23/2009)....23/PRNewswire/--BioTrendsResearchGroup,Inc.releas...t,thesecondinamulti-phasesyndicatedmarketresearchp...raheme,throughthefirstsixmonthsofproductavailabili...ionfrom50uniqueNephrologistsandqualitativeinformat...raheme,obstaclestouse,reasonstouse,typicalpatientt...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--CordBloodAmerica,Inc.(OT...preservationcompany( http://www.cordblood-america....cells,abiologicalinsurancepolicy,tofamiliesnationw...rogressinterviewwithCEOandco-founderMatthewSchissl...tp://blip.tv/file/2875811 . ,, Intheinterview,M...
(Date:11/23/2009)...l.,Nov.23/PRNewswire/--SagentPharmaceuticals,Inc.,...focusoninjectableproducts,todayannouncedthatJeffer...oftheboardofSagentPharmaceuticals,willpresentatthe...y,December1,2009at9:30ameasterntimeattheNewYorkPal...ceuticals,Inc. ,, SagentPharmaceuticals,founde...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimers 51408 1Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimers 51408 2Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimers 51408 3Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimers 51408 4Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimers 51408 5iCRco Wins Government CR Contract with United States Coast Guard 51403 1iCRco Wins Government CR Contract with United States Coast Guard 51403 2iCRco Wins Government CR Contract with United States Coast Guard 51403 3Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 9226 1Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 9226 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 9226 3... 19 , - New Funds to Drive Clinical Developme...erapy for Heart Failure , Cardio3 BioSciences,...ing,in cell-based therapies for the treatment of c...in a successful Series B fund raising round. The n...existing investors, will be,used to finance the cl...
...g 1,000-Times the Dosage Recommended for Humans Sh...Support the Potential for Weekly or Bi-Monthly Dos...odigene Inc. (OTC Bulletin Board: MODG) today repo...es designed to assess the safety of hGH-CTP, its l...to provide preliminary information on the approxim...
Other Medicine Technology:Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 2Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 3Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 4Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 5Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 2Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 3Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 4(Date:11/23/2009)...PRNewswire-USNewswire/-- The AmericanLegislativeE...membershipassociationofstatelegislators,congratula...e-filinga constitutionalamendment toprotecttherigh...hCarolinanowbecomesthe24thstatewherelegislatorshav...rALEC,s FreedomofChoiceinHealthCareAct . ,, (Lo...
(Date:11/23/2009)...ov.23/PRNewswire-USNewswire/--SouthamptonHospitala...illiontofundanewEmergencyDepartment.Thegiftisthela...ltoalmostdoubletheexistingspaceandgreatlyexpandits...SouthForkofLongIsland. ,, Scheduledforcompletio...ent willprovideacentralizedtraumanurses,stationand...
(Date:11/23/2009)...ewswire/--Howistheeconomyaffectingpeople,swellness...ssonWellness&theEconomy,theeconomyismakingusco...ifestyleofexerciseanddiettoonethatismoreinwardlyfo...urvey,smostdramaticfindingwasthechangeinconsumers,...ocusonhealthandwellbeingtotoday,smorerelevantconce...
(Date:11/23/2009)...air breathing, protein may be the cause , ...archers say they,ve identified a protein that cau...rcent of people with chronic sinusitis. , The c...itis, a constant irritation and swelling of the na...nus tissue -- can block the sinus passages and mak...
(Date:11/23/2009)...osure shortly after birth to ambient metals from r...om diesel emissions are associated with respirator... to a new study by researchers at the Columbia Cen... Columbia University,s Mailman School of Public He...ts of exposure to airborne metals in this very you...
Breaking Medicine News(10 mins):Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2[1] South Carolina Now 24th State to Defend Health Care Choice[0] Southampton Hospital Receives $5 Million Gift for New Emergency Department[0] Being Well Is About Reinvention - Not Health[0] Research Yields Clues to Severe Form of Sinusitis[0] Exposures to metals and diesel emissions in air linked to respiratory symptoms in children
...st the caffeine content of beverages such as tea, ...ou can now clear your suspicion about the decaf la...he home based kit, produced by researchers at Wash... Chemistry, a publication of the American Chemical...
...ishop of Canterbury, has warned that National Heal...ystem could compromise the quality and centrality ...ad of the Church of England suggested that "short-...gathered for the annual Florence Nightingale Comme...
...to enter into partnership with real estate agents ...o new homes. //
The vicar will offer his servi...prayers are intended to cover almost every eventua...nterest in practices such as feng shui, demonstrat...
... private medical college described the Budhia’s me... panel of Government doctors who had examined the ...g such long distances. According to the report of ...ls were higher. In view of high blood pressure, th...
...s Interuniversity Institute for Biotechnology (VIB...say that Sorafenib (Nexavar) is a better drug than... They said that although Glivec has a good track r...L patients, but it also provides a new approach fo...
...t new targets to the government on HIV/AIDS, tuber...capital. a major resolution was passed,// declarin...m these diseases should have access to HIV/AIDS tr...hese will be met. The doubt is mainly because of t...
Other Medicine News:Health News:Caffeine Content In Beverages To Be Identified By Home Test Kit 2Health News:Head Of The Church Of England Asks NHS To Respect Patient Needs 2Health News:New Home New Blessings 2Health News:Leukemia Gets A New Drug 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |